Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Tang Capital Management LLC reported a 8.40% stake in Cytomx Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Tang Capital Management LLC reported a 8.40% stake in Cytomx Therapeutics, Inc., 6,717,825 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 8.40%
- Shares
- 6,717,825
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 8.40% | 6,717,825 |
| KEVIN TANG | 8.40% | 6,717,825 |
| TANG CAPITAL PARTNERS, LP | 6.20% | 4,964,773 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 2.20% | 1,753,052 |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 |
Source
Related
- Cytomx Therapeutics, Inc.
- Tang Capital Management LLC
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G/A · Tang Capital Management LLC · Feb 17, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2025
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026